PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...
Vous n'êtes pas connecté
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure with mildly reduced ejection fraction or heart failure with preserved ejection fraction (HFpEF)...
PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...
THURSDAY, Sept. 12, 2024 -- Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney...
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought,...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
FRIDAY, Sept. 13, 2024 -- For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication...